Supplement Presents Studies on Importance of Simpler Diagnostics for Infectious Diseases
By LabMedica International staff writers Posted on 07 Dec 2015 |
The Diagnostics Modelling Consortium (DMC) and the Gates Foundation have published a supplement of papers on their latest research outcomes across a range of infectious diseases that affect developing world countries, emphasizing that improved, well-considered field diagnostics could support elimination of multiple diseases. Studies included the use of mathematical modeling to predict impact of new diagnostic tools.
One of the studies, led by researchers from Imperial College London (London, UK), found that wider use of the pulse oximeter (the finger-clip device that measures blood oxygen and pulse) could prevent 148,000 pneumonia deaths in the under-fives in countries where the disease is most prominent. "This is a very simple tool that could have a very big impact," said paper senior author Prof. Azra Ghani, Imperial's School of Public Health and director of the DMC.
Routinely used in hospitals, pulse oximetry is a simple, noninvasive technology that can help diagnose conditions, such as pneumonia, that trigger low oxygen levels. The device is not routinely available in community settings, where pneumonia is often diagnosed via counting the number of breaths per minute, and observing whether a child is sucking their chest under the rib cage, suggesting a struggle to breathe. The researchers argue that pulse oximetry could allow children to be more quickly diagnosed and sent to hospital for life-saving oxygen and antibiotics. However, they caution, improvement also depends on having access to a nearby hospital or medical facility.
In another paper, researchers call for investment to improve diagnostic screening tools for detection of people who are infected but asymptomatic. For example, current tests for malaria, which involve blood finger-prick sampling, can identify only about 50% of carriers, from whom infection can be transmitted further. Detecting a 10-fold lower density of parasites in blood could increase detection rate to over 80%. “Increasing the sensitivity of these tests could improve the prospect of malaria elimination,” said Dr. Hannah Slater, Imperial’s School of Public Health and lead author of one of the malaria papers. With recent investment from the UK government and the Bill and Melinda Gates Foundation it is hoped that malaria could be eradicated in the next 30 years.
Another paper calls for expanded use and improvement of rapid diagnostic tests for Ebola. In the recent outbreak, Ebola testing took 2–7 days, during which patients remained in a holding area where infected and uninfected patients stayed together until their results came in, increasing the risk of contracting Ebola and taking up limited bed capacity. The authors calculated that if rapid tests had been available and used from the start, the scale of the outbreak could have reduced by a third. “The availability of a rapid diagnostic test could have had a dramatic impact on the epidemic and is therefore a priority for future investment, said lead author Dr. Pierre Nouvellet, Imperial’s School of Public Health.
Other papers in the supplement explore similar issues for HIV, TB, or neglected tropical diseases. "Developing effective tests to diagnose disease is critical to guide use of other interventions, such as drugs and vaccines," said Prof. Ghani, “They therefore have the potential to save lives by directing resources to those most in need.”
The supplement was published December 3, 2015, in the journal Nature under contractual agreement with and funding by the Bill and Melinda Gates Foundation and. Content was not written or reviewed by Nature editors.
Related Links:
Imperial College London
Supplement: Infectious disease control and elimination - Modelling the impact of improved diagnostics
One of the studies, led by researchers from Imperial College London (London, UK), found that wider use of the pulse oximeter (the finger-clip device that measures blood oxygen and pulse) could prevent 148,000 pneumonia deaths in the under-fives in countries where the disease is most prominent. "This is a very simple tool that could have a very big impact," said paper senior author Prof. Azra Ghani, Imperial's School of Public Health and director of the DMC.
Routinely used in hospitals, pulse oximetry is a simple, noninvasive technology that can help diagnose conditions, such as pneumonia, that trigger low oxygen levels. The device is not routinely available in community settings, where pneumonia is often diagnosed via counting the number of breaths per minute, and observing whether a child is sucking their chest under the rib cage, suggesting a struggle to breathe. The researchers argue that pulse oximetry could allow children to be more quickly diagnosed and sent to hospital for life-saving oxygen and antibiotics. However, they caution, improvement also depends on having access to a nearby hospital or medical facility.
In another paper, researchers call for investment to improve diagnostic screening tools for detection of people who are infected but asymptomatic. For example, current tests for malaria, which involve blood finger-prick sampling, can identify only about 50% of carriers, from whom infection can be transmitted further. Detecting a 10-fold lower density of parasites in blood could increase detection rate to over 80%. “Increasing the sensitivity of these tests could improve the prospect of malaria elimination,” said Dr. Hannah Slater, Imperial’s School of Public Health and lead author of one of the malaria papers. With recent investment from the UK government and the Bill and Melinda Gates Foundation it is hoped that malaria could be eradicated in the next 30 years.
Another paper calls for expanded use and improvement of rapid diagnostic tests for Ebola. In the recent outbreak, Ebola testing took 2–7 days, during which patients remained in a holding area where infected and uninfected patients stayed together until their results came in, increasing the risk of contracting Ebola and taking up limited bed capacity. The authors calculated that if rapid tests had been available and used from the start, the scale of the outbreak could have reduced by a third. “The availability of a rapid diagnostic test could have had a dramatic impact on the epidemic and is therefore a priority for future investment, said lead author Dr. Pierre Nouvellet, Imperial’s School of Public Health.
Other papers in the supplement explore similar issues for HIV, TB, or neglected tropical diseases. "Developing effective tests to diagnose disease is critical to guide use of other interventions, such as drugs and vaccines," said Prof. Ghani, “They therefore have the potential to save lives by directing resources to those most in need.”
The supplement was published December 3, 2015, in the journal Nature under contractual agreement with and funding by the Bill and Melinda Gates Foundation and. Content was not written or reviewed by Nature editors.
Related Links:
Imperial College London
Supplement: Infectious disease control and elimination - Modelling the impact of improved diagnostics
Latest Microbiology News
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
- Culture-Free Platform Rapidly Identifies Blood Stream Infections
- POC PCR Test Rapidly Detects Bacterial Meningitis Directly at Point of Sample Collection
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism
Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more
New Biomarkers to Improve Early Detection and Monitoring of Kidney Injury
Drug-induced kidney injury, also known as nephrotoxicity, is a prevalent issue in clinical practice, occurring when specific medications at certain doses cause damage to the kidneys. Nephrotoxicity can... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read moreCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read morePathology
view channel
AI Model Predicts Patient Response to Bladder Cancer Treatment
Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read more
New Laser-Based Method to Accelerate Cancer Diagnosis
Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published... Read more
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read moreTechnology
view channel
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
Tecan Group (Männedorf, Switzerland) has entered into an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS (Codolet, France), a subsidiary of the... Read more